Trial Profile
Safety and Efficacy of Lopinavir/Ritonavir in Combination With Raltegravir in HIV-Infected Patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Raltegravir
- Indications HIV-1 infections
- Focus Therapeutic Use
- 19 Jul 2011 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 19 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Sep 2008 New trial record.